CorMedix, Inc. (CRMD)
7.02
+0.23
(+3.39%)
USD |
NASDAQ |
Apr 01, 16:00
7.02
0.00 (0.00%)
After-Hours: 20:00
CorMedix Research and Development Expense (TTM) : 19.33M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Amicus Therapeutics, Inc. | 135.84M |
| Pfizer Inc. | 10.25B |
| Indivior Pharmaceuticals, Inc. | 80.00M |
| Altimmune, Inc. | 66.32M |